BCIQ Profiles

Company Profile Report
0525 QTs
BioCentury & Getty Images

Regulation

May 25 Quick Takes: Moderna to submit pediatric COVID vaccine data to regulators in early June; plus FDA guidance on bispecifics, TG, Asylia, Pieris, Nordic, Ziphius and Kyma

May 26, 2021 | 1:18 AM GMT

Moderna Inc. (NASDAQ:MRNA) will be the next company to bring a COVID-19 vaccine forward for authorization in adolescents, with plans to submit data from the Phase II/III TeenCOVE study of its COVID-19 vaccine to regulators early

Read the full 732 word article

How to gain access

Continue reading with a
two-week free trial.